Obesity and hypertension: two epidemics or one?
The association between obesity and hypertension is well documented, although the exact nature of this relation remains unclear. Sympathetic nervous and renin-angiotensin-aldosterone system activation appear to play an important role in the sodium and water retention, rightward shift in the pressure-natriuresis, and blood pressure elevation observed in obese individuals. Visceral obesity and the ectopic deposition of adipose tissue may be important in the activation of these systems and in the target organ damage that ensues. Weight loss is critical in the effective management of obesity hypertension and the accompanying target organ damage, although recidivism rates are high. However, prevention of weight gain should be the major priority for combating hypertension and its consequences in the future. The present review will provide an overview of our understanding of the etiology, pathophysiology, and treatment of obesity hypertension. Our focus is on the state of knowledge in humans. The potential role of abdominal obesity is considered throughout our review. We refer to relevant animal literature for supportive evidence and where little or no data in humans are available.
Davy
Kevin P
KP
Dept. of Human Nutrition, Foods, and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA. kdavy@vt.edu
Hall
John E
JE
D000818:Animals; D004196:Disease Outbreaks; D006801:Humans; D006973:Hypertension / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D009765:Obesity / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy